InsidersTradesSigma
Explore the complete record of transactions filed by TOMSICEK MICHAEL JOHN. Officer active across 1 companies, notably CRISPR Therapeutics AG. Aggregated, 2 disclosures have been published. The latest transaction was disclosed on 6 August 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations